Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 223 Carboplatin 218 Cisplatin 205 Paclitaxel 182 Gemcitabine 149 Docetaxel 127 Capecitabine 114 Dexamethasone 102 Pemetrexed 101 Cyclophosphamide 101 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 96 Radiotherapy 95 Doxorubicin 91 Fluorouracil 87 Bevacizumab 83 Nivolumab 74 Leucovorin 72 Rituximab 70 Vincristine 67 durvalumab 66 Lenalidomide 63 Etoposide 62 atezolizumab 61 Radiation 61 Irinotecan 60 130-nm albumin-bound paclitaxel 57 Prednisone 56 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × 4-fluorobenzoyl-TN-14003 × 1 year × Clear all

NCT03246529 2026-01-15

GENESIS

BioLineRx, Ltd.

Phase 3 Active not recruiting

180 enrolled 22 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡